# Reproductive System

## Etiology of Incresed Exposure to Estrogen

- Nulliparity
- Early menarche
- Late menopause

## Side Effects of Unopposed Estrogen

- ↑ Thromboembolism
- ↑ Breast cancer
- ↑ Endometrial cancer
- ↑ Bone mineral density

## Etiology of Peripheral Precocious Puberty

- Congenital adrenal hyperplasia
- Adrenal tumors
- Gonadal tumors
- McCune-Albright syndrome
- Exogenous sex hormone

## Etiology of Abnormal Uterine Bleeding (AUB) {PALM-COEIN}

- Pregnancy
- Polyps
- Adenomyosis
- Leiomyoma
- Malignancy
- Coagulopathy
- Ovulatory dysfunction
- Endometrium
- Iatrogenic
- Not yet classified

## Classification of Amenorrhea

- Primary: no menarche by age 15 years
- Secondary: no menses for ≥ 3 cycles / ≥ 6 months

## Etiology of Primary Amenorrhea

|Etiology|Breast|Uterus|Ovary|
|-|-|-|-|
|Outflow obstruction|+|+|+|
|Anorexia nervosa|+|+|+|
|Mullerian agenesis|+|-|+|
|Androgen insensitivity syndrome (AIS)|+|-|-|
|Constitutional growth delay|-|+|+|
|Hypogonadotropic Hypogonadism|-|+|+|
|Turner syndrome|-|+|+|
|Swyer syndrome|-|+|-|

## Etiology of Secondary Amenorrhea

|Etiology|GnRH|LH & FSH|SH|
|-|-|-|-|
|Pregnancy|↓|↓|↑|
|Menopause [Ovarian failure]|↑|↑|↓|
|Resistant ovary [Savage] syndrome|↑|↑|↓|
|Hypogonadotropic Hypogonadism|↓|↓|↓|
|Polycystic ovary syndrome (PCOS)|↑/↓|↑/↓|↓/↑|
|Asherman syndrome|-|-|-|
|Outflow obstruction|-|-|-|

## Indicators of Ovarian Reserve

|Indicator|Normal|
|-|-|
|FSH :: follicular phase|2 ~ 8|
|Anti-Mullerian hormone (AMH)|1 ~ 5|
|Antral follicle count (AFC)|5 ~ 10|

## Presentation of Menopause {HAVOCS}

- Hot flashes
- Atrophy of the vagina
- Osteoporosis
- Cardiovascular disease
- Sleep disturbances

## Treatment of Menopause

- Topical estrogen
- Hormone replacement therapy (HRT)
- SSRIs & SNRIs
- Calcium & Vitamin D supplements

## Side Effects of Hormone Replacement Therapy (HRT)

- ↑ Thromboembolism
- Breast cancer
	- ↑ if estrogen + progesterone
	- ↓ if estrogen alone
- Endometrial cancer
	- ↓ if estrogen + progesterone
	- ↑ if estrogen alone
- ↓ Fractures

## Hormones Changes in PCOS

|Hormone|Changes|
|-|-|
|GnRH|↑/↓|
|LH|↑|
|FSH|↓|
|LH/FSH|↑|
|Progesterone|↓|
|Testosterone|↑|
|Estrogen|↑|

## Rotterdam Criteria for Diagnosis of PCOS

- Anovulation
- Hyperandrogenism
- Polycystic ovaries

## Treatment of PCOS

- Ovulation induction
	- Estrogen modulators :: Clomiphene
	- Aromatase inhibitors
- Combined hormonal contraception
- Androgen antagonists
- 5α-Reductase inhibitors
- Metformin ± Statins
- Lifestyle modification

## Non-surgical Treatment of Pelvic Organ Prolapse (POP)

- Kegel exercise
- Topical estrogen
- Pessary

## Pathogens of Genital Tract Infection

|Pathogen|Presentation|Treatment|
|-|-|-|
|Neisseria gonorrhoeae|Discharge :: greenish-yellow<br>Pelvic inflammatory disease (PID)|3° Cephalosporins<br>Macrolides|
|Haemophilus ducreyi|Painful chancroid|-|
|Klebsiella granulomatis|Granuloma inguinale|Macrolides<br>Doxycycline|
|Treponema pallidum|Painless chancre<br>Condyloma lata|Penicillin|
|Chlamydia trachomatis|Discharge :: greenish-yellow<br>Lymphogranuloma venereum (LGV)<br>Pelvic inflammatory disease (PID)|Macrolides<br>Doxycycline|
|Gardnerella vaginalis|Discharge :: grayish & fishy|Metronidazole|
|Candida albicans|Discharge :: white & curdy|-Conazoles|
|Trichomonas vaginalis|Discharge :: greenish-yellow & frothy|Metronidazole|
|HPV|Condyloma accumulata<br>Verruca vulgaris|-|
|HSV|Paniful ulcers|-|

## Comparison Between Testicular Torsion and Epididymitis

||Testicular Torsion|Epididymitis|
|-|-|-|
|Prehn sign|-|+|
|Cremasteric reflex|-|+|
|Blood flow|↓|↑|

## Medications for BPH

|Mechanism|Medication|
|-|-|
|α<sub>1</sub> antagonists|Tamsulosin<br>Terazosin<br>Doxazosin<br>Prazosin|
|5α-Reductase inhibitors|Finasteride|

## Reproductive Tumors

### Epithelial Tumors

- Serous cystadenoma & cystadenocarcinoma
- Mucinous cystadenoma & cystadenocarcinoma
- Endometrioid carcinoma
- Clear cell carcinoma
- Transitional cell carcinoma [Brenner tumor]

### Stromal Tumors

|Female|Male|Markers|
|-|-|-|
|Theca cell tumor [Thecoma]|Leydig cell tumor|-|
|Granulosa cell tumor|Sertoli cell tumor|Inhibin|
|Fibroma|Fibroma|-|

### Germ Cell Tumors (GCT)

|Female|Male|Markers|
|-|-|-|
|Dysgerminoma|Seminoma|ALP & LDH|
|Choriocarcinoma|Choriocarcinoma|hCG|
|Yolk sac tumor|Yolk sac tumor|AFP|
|Embryonal carcinoma|Embryonal carcinoma|hCG & AFP|
|Teratoma|Teratoma|hCG & AFP|

### Mixed Epithelial and Stromal Tumor 

- Carcinosarcoma [Malignant mixed Mullerian tumor (MMMT)]

## Triad of Meigs Syndrome

- Ovarian fibroma
- Pleural effusion
- Ascites

## Types of Endometrial Cancer

|Type|1|2|
|-|-|
|Histology|Endometrioid|Non-endometrioid|
|Risk factors|Estrogen|-|
|Prognosis|Favorable|Poor|

## Bethesda System for Pap Smear Results

- Squamous cell abnormalities
	- Atypical squamous cell (ASC)
	- Low-grade squamous intraepithelial lesion (LSIL)
	- High-grade squamous intraepithelial lesion (HSIL)
	- Squamous cell carcinoma
- Glandular cell abnormalities
	- Atypical glandular cell (AGC)
	- Adenocarcinoma in situ (AIS)
	- Adenocarcinoma

![](../Figures/Bethesda%20System%20for%20Pap%20Smear%20Results.jpg)

## Management of Abnormal Pap Smear Results

|Result|Age (years)|HPV|Management|
|-|-|-|-|
|-|< 30|±/?|Routine screening|
|-|> 30|-/?|Routine screening|
|-|> 30|+|Repeat screening in 1 year|
|ASC-US|< 25|-|Routine screening|
|ASC-US|< 25|+/?|Repeat screening in 1 year|
|ASC-US|> 25|-|Repeat screening in 3 years|
|ASC-US|> 25|?|Repeat screening in 1 year|
|LSIL|< 25|±/?|Repeat screening in 1 year|
|LSIL|> 25|-|Repeat screening in 1 year|
|Consecutive<br>Otherwise|Any|±/?|Colposcopy ± Biopsy|

## Management of Cervical Intraepithelial Neoplasia (CIN)

|CIN|Management|
|-|-|
|I|Repeat screening in 1 year|
|II<br>III|Cryotherapy<br>Laser ablation<br>Conization<br>Loop electrosurgical excision procedure (LEEP)|

## Management of Seminoma

- Radical orchiectomy
- Radiotherapy
- Chemotherapy

## Contraception Methods

- Barrier contraception
- Combined hormonal contraception
	- Oral contraceptive pills (OCPs)
	- Contraceptive patch
	- contraceptive ring
- Depot medroxyprogesterone
- Progestin subdermal implant
- Intrauterine devices
	- Progestin intrauterine device
	- Copper intrauterine device

## Side Effects of Combined Hormonal Contraception

- ↑ Thromboembolism
- ↑ Breast cancer
- ↓ Endometrial cancer
- ↓ Ovarian cancer

## Contraindications to Combined Hormonal Contraception

- Age ≥ 35 years<br>Smoking ≥ 15 cigarettes/day
- History of thromboembolism
- Active breast cancer
- Liver failure
- Migraines with aura

## Contraindications to Intrauterine Device (IUD)

- Pregnancy
- Unexplained vaginal bleeding
- Endometrial cancer
- Cervical cancer
- Pelvic inflammatory disease (PID)

## Indications for Assisted Reproductive Technology (ART)

### Intrauterine Insemination (IUI)

- Cervical factors
- Male factors
- Donor sperms

### In Vitro Fertilization (IVF)

- Tubal factors
- Donor eggs
- Genetic screening
- Failed intrauterine insemination (IUI)

## Controlled Ovarian Hyperstimulation

### Suppression of Spontaneous Ovulation

|Protocol|Timing|
|-|-|
|GnRH agonist long protocol|Last luteal phase|
|GnRH agonist short protocol|Menstruation|
|GnRH antagonist protocol|Leading follicle > 14 mm|

### Ovulation Induction

- (Follicles > 18 mm) ≥ 2
- Estradiol per co-dominant follicle > 200 pg/mL

|Mechanism|Medication|
|-|-|-|
|GnRH agonists|Leuprolide|
|hCG agonists|Choriogonadotropin|

![](../Figures/Controlled%20Ovarian%20Hyperstimulation.png)
